[CIS PIDD] [cis-pidd] severe WAS and lymphadenopathy

CIS-PIDD cis-pidd at lists.clinimmsoc.org
Thu Jul 28 18:33:38 EDT 2016


Thanks for your thoughts.

The lymph node size was a typo, apologies.  Originally 0.8 x 1.4cm (around 2 months in between scans).
I would say it is on the early side for B cells to have returned but not too extraordinary.

I'll discuss with IR team and see their thoughts on approaching the nodes.

Blachy J. Dávila Saldaña, MD
Attending Physician, Division of Blood and Marrow Transplantation
Children's National Health System
Assistant Professor of Pediatrics
George Washington University School of Medicine and Health Sciences
111 Michigan Avenue, N.W.
Washington, DC 20010
Phone: 202-476-4561
Fax: 202-476-2280


From: CIS-PIDD [mailto:cis-pidd at lists.clinimmsoc.org]
Sent: Thursday, July 28, 2016 11:19 AM
To: CIS-PIDD
Subject: RE: [cis-pidd] severe WAS and lymphadenopathy

I agree with your concern about going in to BMT with HSM and LAN of unclear origin. The CT scan mentions that the paraaortic lymph node measure 1.1 x 1.9 cm, having previously measured 8.4x1.4 cm.  Is that a typo, or was it really 8.4 cm, perhaps prior to rituxan? That would make me more concerned about malignant lymphadenopathy.

In a patient of mine with WAS and equivocal LAN, a colleague suggested an FNA with FACS for kappa and lambda light chains. While FNA is not appropriate for diagnosing lymphoma, a finding of light chain restriction would suggest a clonal lymphoproliferation, which then would justify the further risk of biopsy. A finding of normal K/L ratio would argue against monoclonality and could justify proceeding to BMT without a tissue diagnosis.

I have not seen EMH in WAS, and found only two papers on the subject. One describes EMH in the spleen and LNs, but not in the liver  (Human pathology, 12:821, 1981). The other was not available to me. The citation is, Rinsho Ketsueki. 1998 Feb;39(2):133-4. The EMH also makes me concerned, although presumably the EMH it explained by severe autoimmune cytopenias.


--
Rob Sokolic, MD
Medical Officer
Office of Cellular, Tissue and Gene Therapies
Center for Biologics Evaluation and Research
Food and Drug Administration
White Oak Building 71, Room 5261
10903 New Hampshire Ave
Silver Spring, MD 20993-0002
Robert.Sokolic at fda.hhs.gov<mailto:Robert.Sokolic at fda.hhs.gov>
(240) 402-5564
FAX: (301) 595-1305

The above transmission is meant solely for the addressee. The information contained in this message may be of a private, medical, privileged or industrial nature, and may not be communicated beyond the initial recipient. If you are not the intended recipient of this message or the agent of such recipient, please destroy all physical copies of this message, delete all electronic copies and notify the sender of the error

This communication does not constitute a written advisory opinion under 21 CFR 10.85, but rather is an informal communication under 21 CFR 10.85(k) which represents my best judgment at this time, but does not necessarily represent the formal position of FDA, and does not bind or otherwise obligate or commit the agency to the views expressed.

From: CIS-PIDD [mailto:cis-pidd at lists.clinimmsoc.org]
Sent: Wednesday, July 27, 2016 5:51 PM
To: CIS-PIDD
Subject: [cis-pidd] severe WAS and lymphadenopathy

Dear all;

  Would love to hear your thoughts on a complicated patient regarding possible etiologies and workup.

  We are caring for an 8 month old male with WAS (c.58C>T, p.Q20, minimal protein expression) who is pre BMT.  Complications have included coombs positive hemolytic anemia, controlled post steroids and ritux, autoimmune neutropenia, requiring occasional GCSF but responsive to IgG, and ITP, also responsive to IgG.  He has had hepatosplenomegaly for the past 4 months with mild transaminitis.  Infectious studies were negative; liver biopsy reviewed here and at NIH showed some glycogenosis and extramedullary hematopoiesis, but no other pathologic finding.

  His pre BMT CT scans now show periaortic lymphadenopathy, not overtly huge (1 x 2cm biggest one), with scattered shotty axillary/inguinal nodes that are unfortunately too small and not reproducible on exam nor ultrasound.  PET CT also shows scattered retroperitoneal, porta hepatic and splenic lymph nodes of mild uptake (max SUV 2.5).   After reviewing imaging with surgery, these are all in challenging positions to biopsy and they would not recommend we pursue them.  Bone marrow in late May was normal except for decrease/near absence in mature myeloid forms (he was neutropenic at the time), I think a part of his autoimmunity.  He is very well appearing and playful despite notable abdominal distention.

Studies so far:

Infectious:

-          EBV, CMV, Adeno pcr negative

-          Aerobic, anaerobic, fungal, AFB cultures negative

-          HHV6, entero, bartonella and urine histo/blasto pending

-          BMT serologies (hep B, C, HIV, HTLV, syphilis, west nile) negative

-          HIV, HTLV, toxoplasma PCR pending

Immunology/chemistry:

-          WBC 3.56

-          Hgb 9.0

-          Plt 23

-          ANC 1780

-          CD3 1097

-          CD4 983

-          CD8 113

-          CD19 262 (around  2months post ritux...previously 0)

-          NK 541

-          Normal chemistries, LDH, uric acid

-          Mild transaminitis (50s) with no hyperbili and normal GGT

-          TCR alpha/beta gamma/delta normal mid may; repeat pending

-          TCR V beta repertoire pending

Imaging:


CT - Vasculature: The abdominal aorta and major branching vasculature are

patent and of normal caliber. The portal venous system is patent.

Increased periaortic lymphadenopathy, index lymph node

conglomerate now measures 1.1 x 1.9 cm(series 3 image 42), previously

8.4 x 1.4 cm. Additionally there is increased inguinal

lymphadenopathy, left greater than right, when compared to prior

(series 602, image 32).



Liver u/s - Within the left lobe of liver there is a 1.1 x 1.0 x 1.3 cm

heterogeneous lesion correlating to the hypermetabolic lesion

visualized on PET (biopsy of which revealed extramedullary

hematopoiesis).  At the portal venous confluence there is an approximately 1.9 x 0.9 x

1.8 cm hyperechoic lobulated lesion demonstrating a small amount of

vascular flow.  No intrahepatic biliary duct dilatation is seen.



Biliary ducts: Normal.

Gallbladder: Normal.

Pancreas: Normal.

Spleen: Mildly enlarged for age.

Doppler:

Main portal vein spectral Doppler: Normal.

Hepatic veins color ultrasound: Normal.


Liver biopsy: The hepatic architecture is preserved. The connective tissue stains show no fibrosis. There is diffuse cell swelling by a pale amphiphilic material consistent with glycogen; this is associated with mild macrovesicular steatosis. There is a mild portal chronic inflammatory infiltrate without significant interface hepatitis. There are rare foci of lobular inflammation. There are scattered individual and small groups of immature to mature myeloid cells. CD34 immunostain shows a normal pattern of endothelial staining. Myeloperoxidase stain highlights myeloid elements. The PAS is intensely positive with removal of staining by diastase. The extramedullary hematopoiesis seen in this biopsy likely relates to the patient's Wiscott-Aldrich syndrome.  CMV, EBER, and adenoviral stains are negative.


  He clearly has very severe WAS, but I am hesitant to go to transplant with unexplained lymphadenopathy and HSM.  There does not seem to be any evidence of EBV.  Has anyone seen EBV negative lymphoproliferation in WAS at such an early age?

  Thanks for your thoughts!

  Blachy

Blachy J. Dávila Saldaña, MD
Attending Physician, Division of Blood and Marrow Transplantation
Children's National Health System
Assistant Professor of Pediatrics
George Washington University School of Medicine and Health Sciences
111 Michigan Avenue, N.W.
Washington, DC 20010
Phone: 202-476-4561
Fax: 202-476-2280


________________________________
Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.

---

You are currently subscribed to cis-pidd as: Robert.Sokolic at fda.hhs.gov<mailto:Robert.Sokolic at fda.hhs.gov>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396896.aa2a546ec4607db5083cfc5e6c9c7870&n=T&l=cis-pidd&o=3764612<https://urldefense.proofpoint.com/v2/url?u=http-3A__cts.dundee.net_u-3Fid-3D96396896.aa2a546ec4607db5083cfc5e6c9c7870-26n-3DT-26l-3Dcis-2Dpidd-26o-3D3764612&d=CwMFAw&c=Zoipt4Nmcnjorr_6TBHi1A&r=rAv0RMEMpdUphtpo9AaBIUmFcJmqZ-IozxRyfFNABKk&m=pfsliSHoFW1dE_1dwleNjbjHNBj6S4eQk5Kab6IZoHY&s=2eSBNv-zMeqVomUisSnMes5Cnet6RF-DII3x-vY5ARY&e=>

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-3764612-96396896.aa2a546ec4607db5083cfc5e6c9c7870 at lyris.dundee.net<mailto:leave-3764612-96396896.aa2a546ec4607db5083cfc5e6c9c7870 at lyris.dundee.net>

---

You are currently subscribed to cis-pidd as: bjdavilas1 at childrensnational.org<mailto:bjdavilas1 at childrensnational.org>.

To unsubscribe click here: http://cts.dundee.net/u?id=101257772.c288ed6a977f295b1281787205c8980d&n=T&l=cis-pidd&o=3765617<https://urldefense.proofpoint.com/v2/url?u=http-3A__cts.dundee.net_u-3Fid-3D101257772.c288ed6a977f295b1281787205c8980d-26n-3DT-26l-3Dcis-2Dpidd-26o-3D3765617&d=CwMFAw&c=Zoipt4Nmcnjorr_6TBHi1A&r=rAv0RMEMpdUphtpo9AaBIUmFcJmqZ-IozxRyfFNABKk&m=pfsliSHoFW1dE_1dwleNjbjHNBj6S4eQk5Kab6IZoHY&s=SLzfLb7_aB_ry66Os14f0H19GPz0xQ-ZO4K9CtooaZQ&e=>

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-3765617-101257772.c288ed6a977f295b1281787205c8980d at lyris.dundee.net<mailto:leave-3765617-101257772.c288ed6a977f295b1281787205c8980d at lyris.dundee.net>

,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.

---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=3766337
or send a blank email to leave-3766337-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20160728/276bc091/attachment-0001.html>


More information about the PAGID mailing list